Deferred Tax Assets, Valuation Allowance of NOVAVAX INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NOVAVAX INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • NOVAVAX INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $1,025,765,000, a 9.7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NOVAVAX INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,025,765,000 -$109,794,000 -9.7% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $1,135,559,000 +$6,618,000 +0.59% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $1,128,941,000 +$108,818,000 +11% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $1,020,123,000 +$4,790,000 +0.47% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $1,015,333,000 +$510,545,000 +101% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $504,788,000 +$139,016,000 +38% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $365,772,000 +$28,257,000 +8.4% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $337,515,000 +$37,653,000 +13% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q4 2017 $299,862,000 -$54,668,000 -15% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 $354,530,000 +$117,674,000 +50% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q4 2015 $236,856,000 +$63,933,000 +37% 31 Dec 2015 10-K 27 Feb 2017 2016 FY
Q4 2014 $172,923,000 +$30,392,000 +21% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q4 2013 $142,531,000 +$7,116,000 +5.3% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q4 2012 $135,415,000 +$9,395,000 +7.5% 31 Dec 2012 10-K 12 Mar 2014 2013 FY
Q4 2011 $126,020,000 31 Dec 2011 10-K 12 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.